34
Quality Score
Emerging
Glycemia
✍️ bumetric analysis
“
Glycemia is an Android app from SRey.net in the Health & Fitness category, currently rated 2.4★ across 121 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 34: Emerging (early traction worth watching). For a Health & Fitness app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Revenue · today and ahead
Today
$500/mo
In 12 months
$437 – $1575
In 24 months
$405 – $3644
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 35/100INDIE TIERlimited signalRevenue Strength
2.7
Product Quality
3.3
Market Position
0.0
Growth Velocity
5.0
Defensibility
5.9
Operational Safety
5.0
Founder Strength
4.7
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 2.38★ across 121 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 1300d ago — possibly dormant.
- ⚠️ Risk: Elevated — dormant (1300d since update).
🎯 For competitors: Vulnerable. Quality drift + slow updates create a clear opening for a fresh competitor with active dev cadence.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K. Portfolio play ($977/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Below-average rating (2.4★)METRIC | −$1,500 | |
| Mature app (9y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Early-stage install base (121 ratings)METRIC | +$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
App Specs
🔐 Own this app? Claim & verify MRR →🔖 v1.51🔄 updated 3y ago📂 Health & Fitness💰 Free🚀 Launched 2016 (9y old)
📝 About this app
Glycemia is a data reader of Abbott FreeStyle libre sensor using NFC technology.
This release is UNOFFICIAL and is NOT supported by Abbot. It must be used AT YOUR OWN RISK.
*************Apparently does not work with USA 14 day sensor version************
VERY IMPORTANT : We highly suggest to test Glycemia with a sensor at end of life (1 day left for example) as similar software report issue depending of smartphone and apparently make the sensor unusable after.
Currently the reader is tested successfully with a Samsung Galaxy S5.
Fast usage :… View full description on the official store →
This release is UNOFFICIAL and is NOT supported by Abbot. It must be used AT YOUR OWN RISK.
*************Apparently does not work with USA 14 day sensor version************
VERY IMPORTANT : We highly suggest to test Glycemia with a sensor at end of life (1 day left for example) as similar software report issue depending of smartphone and apparently make the sensor unusable after.
Currently the reader is tested successfully with a Samsung Galaxy S5.
Fast usage :… View full description on the official store →
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Glycemia
- Developer
- SRey.net
- Bundle ID
- net.srey.android.glycemia
- App Store URL
- Open in App Store
- Category
- Health & Fitness
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.srey.net
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $208/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth121 ratings+46% lifetimeShow 3-year history estimate ▾
Tracked (1 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
More by SRey.net
View all →📦 Portfolio summaryINDIE studio
4apps·$977/mocombined
✓ Diversified — top app contributes 32%; risk spread across portfolio
Full revenue analysis
Read the article-style breakdown for Glycemia: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.